Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • BSE

    Tag: bse

    You Searched For "BSE"
    USFDA completes audit for Dr Reddys Shreveport plant, no observations issued

    USFDA completes audit for Dr Reddys Shreveport plant, no observations issued

    Medical Dialogues Bureau23 Feb 2019 9:30 AM IST
    "The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
    Dr Reddys recalls 2770 bags of Levetiracetam Sodium Chloride injection in US market

    Dr Reddys recalls 2770 bags of Levetiracetam Sodium Chloride injection in US market

    Farhat Nasim22 Feb 2019 11:53 AM IST
    As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Dr Reddys is recalling Levetiracetam in 0.54 per cent Sodium...
    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

    Farhat Nasim21 Feb 2019 9:45 AM IST
    Acetazolamide extended-release capsule is therapeutically equivalent to the reference listed drug, Diamox Sequels, 500 mg, of Teva Branded...
    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Farhat Nasim17 Feb 2019 9:30 AM IST
    The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine...
    GSK Consumer profit rises 35 percent to Rs 221.06 crore in December quarter

    GSK Consumer profit rises 35 percent to Rs 221.06 crore in December quarter

    Garima16 Feb 2019 9:20 AM IST
    "The merger is now subject to the receipt of other necessary statutory and regulatory approvals under applicable laws. The merger process is moving...
    Dr Reddys launches Tadalafil tablets for treating erectile dysfunction

    Dr Reddys launches Tadalafil tablets for treating erectile dysfunction

    Farhat Nasim13 Feb 2019 12:31 PM IST
    New Delhi: Hyderabad based drug major, Dr Reddy's has recently launched Tadalafil tablets in the US market. The drug launched is used to treat...
    Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant

    Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant

    Farhat Nasim8 Feb 2019 11:40 AM IST
    Fulvestrant injection is a generic version of AstraZeneca Pharmaceuticals LP's Faslodex injection in the same strength, it added. The Faslodex...
    Strides to exit investment in Arrow Pharma for over Rs 2000 crore

    Strides to exit investment in Arrow Pharma for over Rs 2000 crore

    Medical Dialogues Bureau30 Jan 2019 9:30 AM IST
    "Strides will receive AUD 300 million as upfront payment at the closure of the transaction, while the balance AUD 94 million to be deferred through a...
    Glenmark gets tentative USFDA nod for Abiraterone Acetate tablets

    Glenmark gets tentative USFDA nod for Abiraterone Acetate tablets

    Medical Dialogues Bureau24 Jan 2019 9:30 AM IST
    Glenmark Pharmaceuticals Inc USA has been granted tentative approval by the United States Food and Drug Administration for Abiraterone Acetate tablets...
    Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report

    Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report

    Farhat Nasim21 Jan 2019 2:13 PM IST
    "Our idea is to focus only on tertiary care in cities and we are exploring new facilities in Mumbai, Pune and in Thiruvananthapuram, where we have...
    Dr Reddy

    Dr Reddy's gets four observations from USFDA for Andhra plant

    Medical Dialogues Bureau19 Jan 2019 9:30 AM IST
    "The audit of our formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US Food and Drug Administration (USFDA), has been completed today....
    Lupin gets USFDA nod for generic schizophrenia drug

    Lupin gets USFDA nod for generic schizophrenia drug

    Medical Dialogues Bureau8 Jan 2019 12:10 PM IST
    New Delhi: Drug maker Lupin Monday said it has received approval from the US health regulator to market Lurasidone Hydrochloride tablets, used in the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok